Search

Learn from MSK experts about how to quit smoking if you have cancer. It starts with having honest conversations about smoking and nicotine addiction.

… Friday, April 5, 2019 Summary Four MSK experts share strategies specifically for people with cancer to help them quit smoking. Most people know that smoking is the leading cause of cancer. But there is much less awareness among people with cancer — and their doctors — that smoking is associated with

Memorial Sloan Kettering Cancer Center has filed an application with the New York State Department of Health to open a freestanding outpatient facility in Harrison, New York. If approved, the new 114,000-square-foot treatment facility will offer area residents the most advanced cancer care services, closer to home.

… Monday, January 31, 2011 Memorial Sloan Kettering Cancer Center has filed an application with the New York State Department of Health to open a freestanding outpatient facility in Harrison, New York. If approved, the new 114,000-square-foot treatment facility will offer area residents the most advanced

Selpercatinib (also known as LOXO-292) is a highly selective RET inhibitor with activity against diverse RET fusions, activating RET mutations and brain metastasis. Phase 1/2 data from the LIBRETTO-001 trial presented at the IASLC 2019 World Conference on Lung Cancer demonstrates selpercatinib’s marked antitumor activity in RET fusion-position non-small cell lung cancer (NSCLC) patients. These findings, presented by Alexander Drilon, MD, principal investigator and Research Director of Early Drug Development at Memorial Sloan Kettering Cancer Center, will form the basis of an US Food and Drug Administration new drug application submission.

… Monday, September 9, 2019 Bottom Line: Selpercatinib (also known as LOXO-292) is a highly selective RET inhibitor with activity against diverse RET fusions, activating RET mutations and brain metastasis. Phase 1/2 data from the LIBRETTO-001 trial presented at the IASLC 2019 World Conference on Lung Cancer

The Gene: An Intimate History is a new four-hour documentary from the award-winning Ken Burns team and PBS, adapted from the award-winning book of the same name by Siddhartha Mukherjee, MD, DPhil. Memorial Sloan Kettering’s Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology, is a featured expert.

… Monday, April 13, 2020 The Gene: An Intimate History is a new four-hour documentary from the award-winning Ken Burns team and PBS, adapted from the award-winning book of the same name by Siddhartha Mukherjee, MD, DPhil. The two-part series brings to life a historical biography of the human genome while

By assuming primitive regenerative identities, cancer cells gain the adaptability they need to establish tumors in new parts of the body.

… Monday, February 10, 2020 Summary Scientists have discovered that cancer cells rely on the biology of regeneration, wound healing, and embryonic development to spread to other organs and escape detection by the immune system. Just as people tend to become stuck in their ways as they grow older so too

Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy.

… Monday, July 11, 2022 Signet ring cell cancer (SRCC) was detected in the vast majority of patients with CDH1 mutations following total gastrectomy, according to a study Memorial Sloan Kettering Cancer Center (MSK) physicians published in JAMA Surgery .  (1) With the increasing availability of genomic

Learn about how MSK staff members recently participated in the 2021 Forbes China Healthcare Summit and spoke about how the war on cancer must be fought internationally with teams collaborating across political boundaries.

… Thursday, September 23, 2021 No one doctor, institution, or country can cure cancer on their own. The war on cancer must be fought internationally with teams collaborating across political boundaries. That was the key message of the 2021 Forbes China Healthcare Summit, which brought together leaders

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

… Monday, May 13, 2019 Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation, according to the results of our study

Learn more about Ken Manotti, who leads philanthropic fundraising efforts at Memorial Sloan Kettering Cancer Center, where he is a Senior Vice President and Chief Development Officer.

… Wednesday, January 1, 2020 Why did you choose philanthropy as a career? I had no plans to be in this profession. But many years ago, a mentor asked me to help with fundraising at the University of Pennsylvania. She was very patient and taught me how to raise money for good causes. Is it hard asking people

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.

… Thursday, September 5, 2024 For most teenagers, the summer before their senior year of high school is a time to hang out with friends, work a part-time job, and start thinking about college applications. But Cody Bass spent that summer recovering from a major operation at Memorial Sloan Kettering Cancer